Your search returned 28 studies. (Get alerts for new studies):
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
Conditions: Chronic Lymphocytic Leukemia (CLL)
2 Locations available
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL - Untreated - Front-line - First-Line - Initial Therapy
4 Locations available
- Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Leukemia
1 Location available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma
Conditions: Acute Lymphocytic Leukemia - Follicular Lymphoma - Chronic Lymphocytic Leukemia (CLL) - Mantle Cell Lymphoma - Prolymphocytic Leukemia - Large Cell Lymphoma
1 Location available
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) - Chronic Lymphocytic Leukemia (CLL) - Non-Hodgkins Lymphoma (NHL) - Cutaneous T Cell Lymphoma (CTCL) - Adult T Cell Lymphoma (ATL)
1 Location available
- Fludarabine, Bendamustine, and Rituximab (FBR) in Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia
1 Location available
- A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocy
Conditions: Monoclonal B-Cell Lymphocytosis
1 Location available
- Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Conditions: CLL - Leukemia
1 Location available
- Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
2 Locations available
- Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL)
7 Locations available
- Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: CLL
2 Locations available
- Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL
1 Location available
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Conditions: B-cell Chronic Lymphocytic Leukemia - Hematopoietic/Lymphoid Cancer - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia
1 Location available
- Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
1 Location available
- Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell
1 Location available
- Phase II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma - Leukemia, Prolymphocytic
1 Location available
- Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Advanced Cancers - Leukemia
1 Location available
- A Study of the Effect of Vinca Alkaloids on JNK Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL)
1 Location available
- A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL)
4 Locations available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic L
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma (SLL)
1 Location available
- Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
|